Home Pharmaceutics UK-wide facility to promote health nanotechnology research

UK-wide facility to promote health nanotechnology research


The University of Strathclyde is going to be the location of a newly commissioned national facility to test pioneering nanotechnologies for healthcare applications.

Image Credit: University of Strathclyde

The Engineering and Physical Sciences Research Council (EPSRC) awarded £ 853,000 to the University to create the Multiscale Metrology Suite (MMS) for next generation health nanotechnologies.

Through this facility, researchers across the UK will have access to leading international technology for the study of materials, facilitating future diagnostic and therapeutic discoveries. It will be a one-of-a-kind facility in the UK, enabling joint chemical and physical analysis of original nanotechnologies.

The combined investment of EPSRC and Strathclyde amounts to more than £ 1.6 million.

Nanotechnology for health is a rapidly growing sector, as evidenced by vaccines developed during the COVID-19 pandemic and the increased use of nanotechnology in cancer diagnostics and therapies.

Dr Zahra Rattray, Principal Investigator of the Project and Chancellor’s Researcher and Lecturer in Translational Pharmacy, Institute of Pharmacy and Biomedical Sciences, University of Strathclyde

Before new drugs enter the clinical arena, early testing of their performance and properties is essential. This investment in MMS gives us a unique ability to be at the forefront of analytical science and to discover much more about the design and performance of these therapies.Added Dr Rattray.

We are excited about the new opportunities the MMS will create with the proposal partners – the government chemist’s lab, the Medicines Discovery Catapult and the Center for Process Innovation – as well as with the wider UK and international nanotechnology communities, to meet the challenges. confronted with the conception of nanomedicine.

Dr Zahra Rattray, Principal Investigator of the Project and Chancellor’s Researcher and Lecturer in Translational Pharmacy, Institute of Pharmacy and Biomedical Sciences, University of Strathclyde

According to Professor Peter Simpson, “At MDC, we have identified that in the UK there are gaps in technology, infrastructure and expertise that make it difficult for innovators to move complex medicines rapidly towards validation and clinical evaluation. , and we are committed to helping fill this gap. “

I am therefore happy to see this metrology suite being created. The facilities will enable better analysis of physicochemical quality attributes for a diverse portfolio of new approaches to healthcare development.

Professor Peter Simpson, Scientific Director, Medicines Discovery Catapult

The study of nanotechnology for healthcare applications is currently a difficult and complicated process, requiring the use of many technologies, which frequently leads to disruptions in the creation of new drugs or to product failures at times of advanced clinical trials.

A modular suite integrating the latest detection technologies in one place, MMS will eliminate existing boundaries in the study of new nanotechnologies by allowing multiple analyzes to be performed on the same sample.

The data produced from these measurements will allow scientists to improve their understanding of the properties that trigger the performance and safety of new drugs based on nanotechnology. It will also provide a framework in which nanotechnology scientists in industry and academia can access the facility, test new models, and create new workflows.

The research is associated with the HealthTech cluster of Strathclyde, one of the six poles of competence in research and application of innovation of the university.

The cluster draws on interdisciplinary know-how in life sciences, engineering, health and social sciences, with industry-related topics in digital health, medical diagnostics and devices. wearable, and advanced rehabilitation, as well as a focus on machine learning, AI for healthcare. , Data Science and Data Analytics.

Source: https://www.strath.ac.uk

Source link


Please enter your comment!
Please enter your name here